Li-Ming Zhang
Li-Ming Zhang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Chang Fei
Hunan University of Medicine, Huaihua, Hunan, 410208, China
2 shared publicationsJun Zhang
Hunan University of Medicine, Huaihua, Hunan, 410208, China
2 shared publicationsLin Wang
Hunan University of Medicine, Huaihua, Hunan, 410208, China
2 shared publicationsYing Zhang
Hunan University of Medicine, Huaihua, Hunan, 410208, China
2 shared publicationsZong-Wei Yi
Hunan University of Medicine, Huaihua, Hunan, 410208, China
2 shared publicationsBo Xiang
1 shared publication
Latest Publications
- 27 November 2021
- Published by Springer Nature in Clinical Rheumatology
- Vol. 41 (3) , 783-793
Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study
Objectives This study aimed to explore differences in clinical features and prognosis among patients with varied myeloperoxidase (MPO) antineutrophil cytoplasmic antibody-associated vasculitis (MPO-AAV) associated lung diseases. Methods Patients with MPO-AAV-associated lung diseases were enrolled in this retrospective cohort study at a single center. Clinical features and laboratory data at the time of diagnosis were compared among patients with various lung disease patterns. Kaplan–Meier and Cox regression analyses were performed to analyze overall survival. Results A total of 155 patients were finally included and categorized into five groups, as follows: 72 had a usual interstitial pneumonia (UIP) pattern, 40 had non-UIP interstitial pneumonia, 18 had bronchiectasis (BR), 13 had necrotizing granuloma (NG), and 12 had diffuse alveolar hemorrhage (DAH). Among the five groups, patients with DAH had higher dyspnea and hemoptysis frequencies, lower PaO2/FiO2 levels, elevated C-reactive protein levels, and the poorest prognosis. The overall survival (OS) in the DAH group (median OS: 3.2 months) was significantly poorer than that in the NG group (median OS: not reached, log rank P < 0.001), the BR group (median OS: not reached, log rank P < 0.001), and the non-UIP IP group (median OS: 61.1 months, log rank P = 0.001). The UIP group had significantly more ex-smokers than the other groups (P < 0.001) and the second poorest survival (median OS: 39.1 months). The NG group tended to have female predominance, a higher incidence of ENT involvement, less severe renal involvement, and the best survival. After adjusting for multi-model Cox regression analysis, DAH and UIP (hazard ratio: 19.301 and 9.940, respectively, compared with NG) were independent predictors of all-cause mortality. Conclusions Various patterns of lung disease-associated MPO-AAV may potentially predict patient survival. Key Point • The present study described the clinical and prognostic features of various lung diseases-associated MPO-AAV, indicating the potential prediction for the survival of MPO-AAV patients.
- 27 November 2021
- Published by Springer Nature in Clinical Rheumatology
- Vol. 41 (3) , 783-793
Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study
Objectives This study aimed to explore differences in clinical features and prognosis among patients with varied myeloperoxidase (MPO) antineutrophil cytoplasmic antibody-associated vasculitis (MPO-AAV) associated lung diseases. Methods Patients with MPO-AAV-associated lung diseases were enrolled in this retrospective cohort study at a single center. Clinical features and laboratory data at the time of diagnosis were compared among patients with various lung disease patterns. Kaplan–Meier and Cox regression analyses were performed to analyze overall survival. Results A total of 155 patients were finally included and categorized into five groups, as follows: 72 had a usual interstitial pneumonia (UIP) pattern, 40 had non-UIP interstitial pneumonia, 18 had bronchiectasis (BR), 13 had necrotizing granuloma (NG), and 12 had diffuse alveolar hemorrhage (DAH). Among the five groups, patients with DAH had higher dyspnea and hemoptysis frequencies, lower PaO2/FiO2 levels, elevated C-reactive protein levels, and the poorest prognosis. The overall survival (OS) in the DAH group (median OS: 3.2 months) was significantly poorer than that in the NG group (median OS: not reached, log rank P < 0.001), the BR group (median OS: not reached, log rank P < 0.001), and the non-UIP IP group (median OS: 61.1 months, log rank P = 0.001). The UIP group had significantly more ex-smokers than the other groups (P < 0.001) and the second poorest survival (median OS: 39.1 months). The NG group tended to have female predominance, a higher incidence of ENT involvement, less severe renal involvement, and the best survival. After adjusting for multi-model Cox regression analysis, DAH and UIP (hazard ratio: 19.301 and 9.940, respectively, compared with NG) were independent predictors of all-cause mortality. Conclusions Various patterns of lung disease-associated MPO-AAV may potentially predict patient survival. Key Point • The present study described the clinical and prognostic features of various lung diseases-associated MPO-AAV, indicating the potential prediction for the survival of MPO-AAV patients.
- Open Access
- 1 May 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 113, 108756
Interleukin-18 promotes fibroblast senescence in pulmonary fibrosis through down-regulating Klotho expression
- 1 May 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 113, 108756
Open AccessInterleukin-18 promotes fibroblast senescence in pulmonary fibrosis through down-regulating Klotho expression
- 1 January 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 508 (2) , 660-666
Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition
- 1 January 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 508 (2) , 660-666
Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition
- Open Access
- 6 January 2010
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 31 (4) , 559-566
microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network
MicroRNAs (miRNAs) are small non-coding RNAs and have been implicated in the pathology of various diseases, including cancer. Here we report that the miRNA profiles have been changed after knockdown of one of the most important oncogene c-MYC or re-expression of a candidate tumor suppressor gene SPLUNC1 in nasopharyngeal carcinoma (NPC) cells. Both c-MYC knockdown and SPLUNC1 re-expression can down-regulate microRNA-141 (miR-141). miR-141 is up-regulated in NPC specimens in comparison with normal nasopharyngeal epithelium. Inhibition of miR-141 could affect cell cycle, apoptosis, cell growth, migration and invasion in NPC cells. We found that BRD3 , UBAP1 and PTEN are potential targets of miR-141, which had been confirmed following luciferase reporter assays and western blotting. BRD3 and UBAP1 are both involved in NPC carcinogenesis as confirmed through our previous studies and PTEN is a crucial tumor suppressor in many tumor types. BRD3 is involved in the regulation of the Rb/E2F pathway. Inhibition of miR-141 could affect some important molecules in the Rb/E2F, JNK2 and AKT pathways. It is well known that carcinogenesis of NPC is involved in the networks of genetic and epigenetic alteration events. We propose that miR-141- and tumor-related genes c-MYC , SPLUNC1 , BRD3 , UBAP1 and PTEN may constitute a gene–miRNA network to contribute to NPC development.
- 6 January 2010
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 31 (4) , 559-566
Open AccessmicroRNA-141 is involved in a nasopharyngeal carcinoma-related genes network
MicroRNAs (miRNAs) are small non-coding RNAs and have been implicated in the pathology of various diseases, including cancer. Here we report that the miRNA profiles have been changed after knockdown of one of the most important oncogene c-MYC or re-expression of a candidate tumor suppressor gene SPLUNC1 in nasopharyngeal carcinoma (NPC) cells. Both c-MYC knockdown and SPLUNC1 re-expression can down-regulate microRNA-141 (miR-141). miR-141 is up-regulated in NPC specimens in comparison with normal nasopharyngeal epithelium. Inhibition of miR-141 could affect cell cycle, apoptosis, cell growth, migration and invasion in NPC cells. We found that BRD3 , UBAP1 and PTEN are potential targets of miR-141, which had been confirmed following luciferase reporter assays and western blotting. BRD3 and UBAP1 are both involved in NPC carcinogenesis as confirmed through our previous studies and PTEN is a crucial tumor suppressor in many tumor types. BRD3 is involved in the regulation of the Rb/E2F pathway. Inhibition of miR-141 could affect some important molecules in the Rb/E2F, JNK2 and AKT pathways. It is well known that carcinogenesis of NPC is involved in the networks of genetic and epigenetic alteration events. We propose that miR-141- and tumor-related genes c-MYC , SPLUNC1 , BRD3 , UBAP1 and PTEN may constitute a gene–miRNA network to contribute to NPC development.